Discovery of (quinazolin-6-yl) benzamide derivatives containing a 6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline moiety as potent reversal agents against P …

W Xue, K Liu, T Zhang, G Dong, J Wang, J Wang… - European Journal of …, 2024 - Elsevier
Abstract P-glycoprotein (P-gp) is an important factor leading to multidrug resistance (MDR)
in cancer treatment. The co-administration of anticancer drugs and P-gp inhibitors has been …
被引用次数：2 相关文章

Discovery of (quinazolin-6-yl) benzamide derivatives containing a 6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline moiety as potent reversal agents against P …

WH Xue, KL Liu, TJ Zhang, G Dong… - European journal of … - pubmed.ncbi.nlm.nih.gov
P-glycoprotein (P-gp) is an important factor leading to multidrug resistance (MDR) in cancer
treatment. The co-administration of anticancer drugs and P-gp inhibitors has been a …

Discovery of (quinazolin-6-yl) benzamide derivatives containing a 6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinoline moiety as potent reversal agents against P …

WH Xue, KL Liu, TJ Zhang, G Dong… - European Journal of …, 2023 - europepmc.org
P-glycoprotein (P-gp) is an important factor leading to multidrug resistance (MDR) in cancer
treatment. The co-administration of anticancer drugs and P-gp inhibitors has been a …